Internal merger of two stepdown subsidiaries into Eugia Pharma

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹1615.00

prior close

₹1625.00

announcement price

After-mkt

timing

Nifty Midcap 150market-0.4%-1.2% vs market

Pharmaceuticals peers, median of 167sector-0.2%-1.5% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Midcap 150 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-1.2

15m

-1.0

30m

-2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6-0.4-1.2-0.2-1.5

Next day

+2.7-0.2+2.8+0.3+2.3

+2.0+0.3+1.8+0.6+1.4

+2.4+0.2+2.2+0.6+1.8

+3.0+0.5+2.5+0.5+2.5

+3.0+0.6+2.4+0.9+2.1

+0.8+0.2+0.5-0.2+1.0

15d

+0.5+0.4+0.1-0.2+0.7

+2.7-1.5+4.1+2.3+0.4

+4.4-6.1+10.5+2.4+2.0

+11.5pendingpending-1.5+12.9

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aurobindo Pharma's board has approved merging two wholly owned stepdown subsidiaries, Eugia Steriles and Eugia SEZ, into Eugia Pharma Specialities, another wholly owned subsidiary. All three make injectable pharma products. FY26 turnovers: Eugia Pharma at about 27,259 million rupees, Eugia SEZ at about 4,874 million rupees, Eugia Steriles at about 63 million rupees. No cash consideration and no change in Aurobindo's shareholding. A Scheme of Amalgamation will be filed with the Hyderabad NCLT.

Likely market impact

Internal restructuring only. No impact on shareholders, shares, or stock price. Expected to cut overheads and simplify the group.